NCT04150107 - A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 17, 2019

Primary Completion Date

February 6, 2020

Study Completion Date

March 12, 2020

Conditions

Type 1 Diabetes

Interventions

DRUG

ORMD-0801 Treatment A

Treatment A: 24 mg (16 mg capsule + 8 mg capsule) Once Daily (QD) at bedtime

DRUG

ORMD-0801 Treatment B

Treatment B: 8 mg (8 mg capsule) three times a day (TID) 45-90 minutes before meals

OTHER

Placebo

Fish oil capsule

Trial Locations (1)

Orange County Research Center, Tustin